New Jersey State Board of Optometrists
Alerts
Page Content
Scam Alert
The Division of Consumer Affairs (Division) is warning all licensed professionals about individuals impersonating New Jersey Division of Consumer Affairs (DCA) investigators, Drug Enforcement Administration (DEA) agents, DEA investigators, New Jersey Drug Control Unit investigators, Federal Bureau of Investigation (FBI) investigators, and other law enforcement personnel, as part of an extortion scheme. The impersonators are contacting licensees by telephone or letter, stating that they are the subject of an investigation. The callers are demanding money to clear up the matter, or threatening to revoke the individual's license. Please be advised that the Division of Consumer Affairs will not contact licensees by telephone to discuss investigations or demand money. Anyone receiving a telephone call from a person purporting to be any of the above mentioned individuals seeking money, should refuse the demand. We encourage you to report the call to the Federal Trade Commission (FTC) at
ReportFraud.ftc.gov. You may also report the call to the Division at
AskConsumerAffairs@lps.state.nj.us. |
|
Optometrist CDS Registration Update
The Optometrist Controlled Dangerous Substances (CDS) Registration has been updated to read “SCH II CDS NOT VALID, EXCEPT FOR HYDROCODONE PRODUCTS”, in accordance with N.J.A.C. 13:38-2.4(h). Optometrists who maintain an active CDS registration will receive an updated registration within the next month. Once the new CDS registration is received, registrants should destroy the old CDS registration.
Please send any questions you may have to
CDS@dca.lps.state.nj.us. |
|
Statutory Change which Allows Optometrists to Prescribe Hydrocodone Containing Products
The Board of Optometry, at its October 21, 2015 Board meeting, has advised the public, pharmacists and pharmacies of the recent statutory change which allows optometrists to prescribe hydrocodone containing products regardless of the controlled substance schedule. The Board of Pharmacy will include a notice in its next quarterly newsletter, place an alert on the Board of Pharmacy website and notify pharmacists and pharmacies of the change via the NJ Prescription Monitoring Program (NJPMP). The Drug Control Unit will place a similar notice on its website.
|
|
Electronic Prescribing of Controlled Substances (EPCS) for a Practitioner
On January 7, 2013 the Board of Pharmacy and Drug Control Unit adopted rules to allow prescribers to issue Schedule II controlled substances prescriptions electronically in accordance with federal requirements. New Jersey practitioners and pharmacies can utilize EPCS for all patient prescriptions.
View EPCS Information |
|
Physician Issuance of Multiple Prescriptions for Schedule II Controlled Substances
The New Jersey Division of Consumer Affairs is re-issuing the following guidance regarding the issuance of multiple prescriptions of a Schedule II controlled dangerous substance by a physician to a patient
View Guidance |
|
Information About the New NJ PMP Law.
In July, Senate Bill 1998 was signed into law (P.L.2015, c.74) which substantially revises the scope and expands the capabilities of the New Jersey Prescription Monitoring Program (NJPMP). The Division of Consumer Affairs is tasked with implementing the new law, which takes effect on November 1, 2015.
View Notice |
|
Information to Pharmacies Regarding Optometrist TPA Certification
The Division of Consumer Affairs, in conjunction with the Board of Pharmacy, is providing the following information concerning Doctors of Optometry (O.D.), Optometrists, and the medication prescriptive authority granted to Optometrists with a Therapeutic Pharmaceutical Agent (TPA) Certification, in order to assist pharmacists and pharmacy personnel in filling prescription issued by Optometrists.
View Notice
|
Last Modified: 3/20/2024 11:10 AM
